Skip to main content

Compare Stocks

Date Range: 

 Infinity PharmaceuticalsMustang BioVYNE TherapeuticsAlpine Immune SciencesTFF Pharmaceuticals
SymbolNASDAQ:INFINASDAQ:MBIONASDAQ:VYNENASDAQ:ALPNNASDAQ:TFFP
Price Information
Current Price$2.72$2.79$3.53$11.83$9.24
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.61.61.61.81.4
Analysis Score4.43.53.53.53.5
Community Score2.02.42.82.52.8
Dividend Score0.00.00.00.00.0
Ownership Score0.81.70.82.50.0
Earnings & Valuation Score0.60.60.60.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$9.00$10.00$21.00$19.40$29.50
% Upside from Price Target230.88% upside258.42% upside494.90% upside63.99% upside219.26% upside
Trade Information
Market Cap$241.12 million$237.64 million$181.40 million$282.70 million$234.36 million
Beta2.41.850.971.722.47
Average Volume3,151,2912,562,2911,951,284113,852354,967
Sales & Book Value
Annual Revenue$3.05 millionN/A$10.64 million$1.74 millionN/A
Price / Sales79.06N/A17.05162.47N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.14 per share$1.25 per share$2.81 per share$1.59 per share$1.50 per share
Price / Book19.43N/A1.267.44N/A
Profitability
Net Income$-47,060,000.00$-46,390,000.00$-73,700,000.00$-41,850,000.00$-11,870,000.00
EPS($0.83)($1.29)($3.09)($2.28)($5.31)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-2,592.65%N/AN/A-606.16%N/A
Return on Equity (ROE)-1,358.77%-90.84%-331.83%-80.38%-59.54%
Return on Assets (ROA)-81.85%-68.47%-210.68%-30.76%-57.08%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.46%0.13%N/A
Current Ratio4.42%9.91%4.92%3.98%26.84%
Quick Ratio4.42%9.91%4.68%3.98%26.84%
Ownership Information
Institutional Ownership Percentage46.66%25.75%50.07%52.86%24.28%
Insider Ownership Percentage13.77%3.39%2.20%76.10%10.40%
Miscellaneous
Employees2362106574
Shares Outstanding88.65 million85.18 million51.39 million23.90 million25.36 million
Next Earnings Date7/29/2021 (Estimated)8/9/2021 (Estimated)8/5/2021 (Estimated)8/10/2021 (Estimated)8/12/2021 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
TFF Pharmaceuticals (TFFP) CEO Glenn Mattes on Q1 2021 Results - Earnings Call TranscriptTFF Pharmaceuticals' (TFFP) CEO Glenn Mattes on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - May 15 at 12:53 PM
TFF Pharmaceuticals (NASDAQ:TFFP) Posts  Earnings Results, Misses Estimates By $0.09 EPSTFF Pharmaceuticals (NASDAQ:TFFP) Posts Earnings Results, Misses Estimates By $0.09 EPS
americanbankingnews.com - May 14 at 10:50 AM
TFF Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business UpdateTFF Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
ca.finance.yahoo.com - May 14 at 8:29 AM
TFF Pharmaceuticals, Inc. (TFFP) Q1 2021 Earnings Call TranscriptTFF Pharmaceuticals, Inc. (TFFP) Q1 2021 Earnings Call Transcript
fool.com - May 14 at 3:24 AM
TFF Pharmaceuticals Inc Registered Shs hosts conference call for investorsTFF Pharmaceuticals Inc Registered Shs hosts conference call for investors
markets.businessinsider.com - May 12 at 6:59 PM
Heres Why Were Not Too Worried About TFF Pharmaceuticals (NASDAQ:TFFP) Cash Burn SituationHere's Why We're Not Too Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Situation
finance.yahoo.com - May 7 at 7:25 PM
TFF Pharmaceuticals (TFFP) Set to Announce Earnings on ThursdayTFF Pharmaceuticals (TFFP) Set to Announce Earnings on Thursday
americanbankingnews.com - May 6 at 3:52 AM
Stock Traders Buy Large Volume of Call Options on TFF Pharmaceuticals (NASDAQ:TFFP)Stock Traders Buy Large Volume of Call Options on TFF Pharmaceuticals (NASDAQ:TFFP)
americanbankingnews.com - May 5 at 6:38 AM
TFF Pharmaceuticals to Hold First Quarter 2021 Financial and Business Results Conference Call on May 13, 2021TFF Pharmaceuticals to Hold First Quarter 2021 Financial and Business Results Conference Call on May 13, 2021
finance.yahoo.com - May 4 at 12:51 PM
TFF Pharmaceuticals Awarded Contract under DARPA’s Next-Generation Personalized Protective Biosystems Program for U.S. WarfightersTFF Pharmaceuticals Awarded Contract under DARPA’s Next-Generation Personalized Protective Biosystems Program for U.S. Warfighters
finance.yahoo.com - April 13 at 3:53 PM
Let’s Jump into the TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Stock ForecastLet’s Jump into the TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Stock Forecast
marketingsentinel.com - March 29 at 5:45 PM
TFF Pharmaceuticals Prices Offering of Common StockTFF Pharmaceuticals Prices Offering of Common Stock
finance.yahoo.com - March 26 at 10:09 AM
TFF Pharmaceuticals Inc. Common Stock (TFFP) Q4 2020 Earnings Call TranscriptTFF Pharmaceuticals Inc. Common Stock (TFFP) Q4 2020 Earnings Call Transcript
finance.yahoo.com - March 19 at 6:50 PM
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Business ResultsTFF Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Business Results
finance.yahoo.com - March 10 at 5:46 PM
Feasibility Arrangement for shelf-stable powder form of messenger RNA COVID-19 Vaccine Candidate announced by GreenLight Biosciences and TFF PharmaceuticalsFeasibility Arrangement for shelf-stable powder form of messenger RNA COVID-19 Vaccine Candidate announced by GreenLight Biosciences and TFF Pharmaceuticals
finance.yahoo.com - March 9 at 8:38 AM
Why Earnings Season Could Be Great for TFF Pharmaceuticals (TFFP)Why Earnings Season Could Be Great for TFF Pharmaceuticals (TFFP)
finance.yahoo.com - March 8 at 2:21 PM
TFF Pharmaceuticals (TFFP) Receives a New Rating from a Top AnalystTFF Pharmaceuticals (TFFP) Receives a New Rating from a Top Analyst
smarteranalyst.com - March 6 at 9:05 AM
TFF Pharmaceuticals to Present at Virtual Investor Conferences in March 2021TFF Pharmaceuticals to Present at Virtual Investor Conferences in March 2021
finance.yahoo.com - March 5 at 9:32 AM
TFFP Mar 2021 15.000 putTFFP Mar 2021 15.000 put
in.finance.yahoo.com - March 3 at 12:26 PM
TFF Pharmaceuticals to Hold Fourth Quarter and Full-Year 2020 Financial Results and Business Results Conference Call on March 10, 2021TFF Pharmaceuticals to Hold Fourth Quarter and Full-Year 2020 Financial Results and Business Results Conference Call on March 10, 2021
finance.yahoo.com - February 24 at 11:26 AM
TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for the United States Army Medical Research Institute of Infectious Diseases ...TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for the United States Army Medical Research Institute of Infectious Diseases ...
businesswire.com - February 19 at 11:53 PM
TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for the United States Army Medical Research Institute oTFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for the United States Army Medical Research Institute o
us.acrofan.com - February 19 at 1:51 PM
TFFP Pharmas Thin Film Freezing Maintains Efficacy For Two Biodefense Countermeasures, Preclinical Studies ShowTFFP Pharma's Thin Film Freezing Maintains Efficacy For Two Biodefense Countermeasures, Preclinical Studies Show
finance.yahoo.com - February 19 at 1:51 PM
TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)
finance.yahoo.com - February 19 at 8:50 AM
TFF Pharmaceuticals to Present at the BIO CEO & Investor Digital ConferenceTFF Pharmaceuticals to Present at the BIO CEO & Investor Digital Conference
finance.yahoo.com - February 12 at 9:09 AM
DateCompanyBrokerageAction
3/24/2021Infinity PharmaceuticalsTruist SecuritiesInitiated Coverage
3/23/2021Infinity PharmaceuticalsB. RileyLower Price Target
3/23/2021Infinity PharmaceuticalsWells Fargo & CompanyBoost Price Target
3/18/2021Infinity PharmaceuticalsTruist FinancialInitiated Coverage
2/25/2021Infinity PharmaceuticalsPiper SandlerInitiated Coverage
2/11/2021Infinity PharmaceuticalsOppenheimerBoost Price Target
2/5/2021Infinity PharmaceuticalsJPMorgan Chase & Co.Upgrade
6/27/2019Infinity PharmaceuticalsCIBCInitiated Coverage
1/7/2019Infinity PharmaceuticalsUBS GroupReiterated Rating
11/9/2020Mustang BioCantor FitzgeraldReiterated Rating
8/11/2020Mustang BioHC WainwrightReiterated Rating
12/17/2020VYNE TherapeuticsMaxim GroupReiterated Rating
10/2/2020VYNE TherapeuticsLifesci CapitalReiterated Rating
10/2/2020VYNE TherapeuticsNorthland SecuritiesReiterated Rating
8/6/2020VYNE TherapeuticsCi CapitalReiterated Rating
5/13/2020VYNE TherapeuticsBarclaysBoost Price Target
3/11/2020VYNE TherapeuticsBank of AmericaInitiated Coverage
10/9/2018VYNE TherapeuticsJefferies Financial GroupLower Price Target
8/26/2020Alpine Immune SciencesCowenInitiated Coverage
6/19/2020Alpine Immune SciencesWedbushBoost Price Target
5/26/2020Alpine Immune SciencesLADENBURG THALM/SH SHReiterated Rating
11/13/2019Alpine Immune SciencesPiper Jaffray CompaniesLower Price Target
8/13/2018Alpine Immune SciencesRaymond JamesInitiated Coverage
6/28/2018Alpine Immune SciencesCitigroupInitiated Coverage
3/4/2021TFF PharmaceuticalsRoth CapitalBoost Price Target
(Data available from 5/15/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.